BOLT vs SOFI · rev $7.7M vs P/E 39, rev $619.4M
Bolt Biotherapeutics (BOLT) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
BOLT currently screens at market cap $11.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the BOLT and SOFI stock pages for the full models.
Not investment advice.